# Litai Zhiyao Raises ~¥50M Seed to Build AI-Native Peptide Drug R&D

On October 10, 2026, per 36Kr, AI-native peptide drug discovery platform Litai Zhiyao completed a near-¥50M seed round co-invested by iFlytek Ventures, L2F Fund and an unnamed industrial investor, for pipeline R&D, compute and patents.



Canonical: https://uniquebase.ai/news/c8c2178b-487f-4e6a-bd24-5db4944294dc
Stable identifier: c8c2178b-487f-4e6a-bd24-5db4944294dc
Snapshot captured: 2026-10-18T08:51:49.337Z
English updated: 2026-10-18T08:52:09.641Z

## Connected profiles

- [Guangyuan L2F Fund](/institutions/guangyuan-l2f-fund)
- [Litaizhiyao](/companies/UB-C9166)
- [Xunfei Venture Capital](/institutions/xunfei-venture-capital)
- [Zhiming Industry Fang](/institutions/zhiming-industry-fang)

## Sources

- https://36kr.com/newsflashes/4021094815960969